Nogapendekin Alfa Inbakicept Combo Yields Disease Control in Glioblastoma
Results from a pilot phase 2 trial showed that all 5 patients who received treatment achieved a response or had stable disease.
Previous Post
Surprising Truths About Bra Hygiene: Are You Washing Yours Enough?
Next Post
Planetary Health at Johns Hopkins
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago